Skip to content

Endoscopic near-total thyroidectomy for differentiated thyroid carcinoma: a multicenter randomized controlled study

Endoscopic near-total thyroidectomy for differentiated thyroid carcinoma: a multicenter randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-10001229
Enrollment
Unknown
Registered
2010-08-18
Start date
2010-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Differentiated Thyroid Carcinoma

Interventions

Open group:classic open near-total thyroidectomy plus radioiodine ablation and TSH suppression therapy
Endoscopic group:endoscopic near-total thyroidectomy plus radioiodine ablation and TSH suppression therapy

Sponsors

Third Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 60 Years

Inclusion criteria

Inclusion criteria: 1. Age=1 cm) found with preoperative color ultrasonography; 4. no tumor invasion of thyroid capsule found preoperatively and intraoperatively; 5. differentiated thyroid carcinoma confirmed histopathologically by preoperative fine needle biopsy or intraoperative excision biopsy; 6. informed consent to endoscopic near-total thyroidectomy or conversion to open surgery and functional neck dissection.

Exclusion criteria

Exclusion criteria: 1. Age>=61 years; 2. with hoarseness caused by tumor invasion of recurrent laryngeal nerve; 3. with metastatic cervical lymph nodes; 4. with tracheal stenosis or deformation caused by tumor compression or invasion; 5. with history of thyroid surgery; 6. rejection to endoscopic surgery; 7. pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
disease free survival rate;total survival rate;

Secondary

MeasureTime frame
time to distant metastasis;time to local-regional recurrence;satisfactory rate of postoperative neck appearance;time to local recurrence;time to regional recurrenc;

Countries

China

Contacts

Public ContactLinjun Fan
flj212@medmail.com.cn+86 0 13389668035

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026